Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268


Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992--2002): estimation methods and prevalence trends.

Cooper HL, Brady JE, Friedman SR, Tempalski B, Gostnell K, Flom PL.

J Urban Health. 2008 Nov;85(6):826-56. doi: 10.1007/s11524-008-9304-9. Epub 2008 Aug 16. Erratum in: J Urban Health. 2008 Nov;85(6):857.


Estimates of the population prevalence of injection drug users among hispanic residents of large US metropolitan areas.

Pouget ER, Friedman SR, Cleland CM, Tempalski B, Cooper HL.

J Urban Health. 2012 Jun;89(3):527-64. doi: 10.1007/s11524-012-9670-1. Erratum in: J Urban Health. 2012 Oct;89(5):873.


Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002.

Brady JE, Friedman SR, Cooper HL, Flom PL, Tempalski B, Gostnell K.

J Urban Health. 2008 May;85(3):323-51. doi: 10.1007/s11524-007-9248-5. Epub 2008 Mar 15.


Residential segregation and injection drug use prevalence among Black adults in US metropolitan areas.

Cooper HL, Friedman SR, Tempalski B, Friedman R.

Am J Public Health. 2007 Feb;97(2):344-52. Epub 2006 Oct 31.


Racial/ethnic disparities in injection drug use in large US metropolitan areas.

Cooper H, Friedman SR, Tempalski B, Friedman R, Keem M.

Ann Epidemiol. 2005 May;15(5):326-34. Review.


Persistent racial/ethnic disparities in AIDS diagnosis rates among people who inject drugs in U.S. metropolitan areas, 1993-2007.

Pouget ER, West BS, Tempalski B, Cooper HL, Hall HI, Hu X, Friedman SR.

Public Health Rep. 2014 May;129(3):267-79.


HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002.

Tempalski B, Lieb S, Cleland CM, Cooper H, Brady JE, Friedman SR.

J Urban Health. 2009 Jan;86(1):132-54. doi: 10.1007/s11524-008-9328-1. Epub 2008 Nov 18.


Contextual Predictors of Injection Drug Use Among Black Adolescents and Adults in US Metropolitan Areas, 1993-2007.

Cooper HL, West B, Linton S, Hunter-Jones J, Zlotorzynska M, Stall R, Wolfe ME, Williams L, Hall HI, Cleland C, Tempalski B, Friedman SR.

Am J Public Health. 2016 Mar;106(3):517-26. doi: 10.2105/AJPH.2015.302911. Epub 2015 Dec 21.


Racialized risk environments in a large sample of people who inject drugs in the United States.

Cooper HL, Linton S, Kelley ME, Ross Z, Wolfe ME, Chen YT, Zlotorzynska M, Hunter-Jones J, Friedman SR, Des Jarlais D, Semaan S, Tempalski B, DiNenno E, Broz D, Wejnert C, Paz-Bailey G; National HIV Behavioral Surveillance Study Group.

Int J Drug Policy. 2016 Jan;27:43-55. doi: 10.1016/j.drugpo.2015.07.015. Epub 2015 Aug 8.


Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996.

Friedman SR, Chapman TF, Perlis TE, Rockwell R, Paone D, Sotheran JL, Des Jarlais DC.

J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):83-91.


Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007.

Tempalski B, Pouget ER, Cleland CM, Brady JE, Cooper HL, Hall HI, Lansky A, West BS, Friedman SR.

PLoS One. 2013 Jun 5;8(6):e64789. doi: 10.1371/journal.pone.0064789. Print 2013.


CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.

Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA; Centers for Disease Control and Prevention (CDC).

MMWR Suppl. 2014 Oct 31;63(4):3-27.


Metropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDS.

Friedman SR, West BS, Pouget ER, Hall HI, Cantrell J, Tempalski B, Chatterjee S, Hu X, Cooper HL, Galea S, Des Jarlais DC.

PLoS One. 2013;8(2):e57201. doi: 10.1371/journal.pone.0057201. Epub 2013 Feb 21.


Racial differences in sexual behaviors related to AIDS in a nineteen-city sample of street-recruited drug injectors. NADR Consortium.

Friedman SR, Young PA, Snyder FR, Shorty V, Jones A, Estrada AL.

AIDS Educ Prev. 1993 Fall;5(3):196-211.


Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America.

Friedman SR, Tempalski B, Brady JE, Friedman JJ, Cooper HL, Flom PL, McGrath MM, Gostnell K, Des Jarlais DC.

Int J Drug Policy. 2007 Dec;18(6):475-85. Epub 2006 Dec 1.


HIV among injection drug users in large US metropolitan areas, 1998.

Friedman SR, Lieb S, Tempalski B, Cooper H, Keem M, Friedman R, Flom PL.

J Urban Health. 2005 Sep;82(3):434-45. Epub 2005 Jul 13.


Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need.

Cooper HL, Bossak BH, Tempalski B, Friedman SR, Des Jarlais DC.

J Urban Health. 2009 Nov;86(6):929-45. doi: 10.1007/s11524-009-9399-7.


Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs - United States.

Wejnert C, Hess KL, Hall HI, Van Handel M, Hayes D, Fulton P Jr, An Q, Koenig LJ, Prejean J, Valleroy LA.

MMWR Morb Mortal Wkly Rep. 2016 Dec 2;65(47):1336-1342. doi: 10.15585/mmwr.mm6547e1.


Surveillance of health status in minority communities - Racial and Ethnic Approaches to Community Health Across the U.S. (REACH U.S.) Risk Factor Survey, United States, 2009.

Liao Y, Bang D, Cosgrove S, Dulin R, Harris Z, Taylor A, White S, Yatabe G, Liburd L, Giles W; Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2011 May 20;60(6):1-44.

Supplemental Content

Support Center